Omada Health, Inc. Proceeds from Stock Options Exercised
Omada Health, Inc. (OMDA) reported Proceeds from Stock Options Exercised of $11.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-07
- Omada Health, Inc. proceeds from stock options exercised for the quarter ending 2026-06-30 was $8.14M, a 172.23% increase year-over-year.
- Omada Health, Inc. proceeds from stock options exercised for the quarter ending 2026-03-31 was $3.25M, a 253.32% increase year-over-year.
- Omada Health, Inc. proceeds from stock options exercised for the quarter ending 2025-12-31 was $3.38M, a 162.85% increase year-over-year.
- Omada Health, Inc. proceeds from stock options exercised for the quarter ending 2025-09-30 was $2.08M, a 213.06% increase year-over-year.
- Omada Health, Inc. proceeds from stock options exercised for fiscal 2025 was $9.37M, a 181.41% increase from fiscal 2024.
- Omada Health, Inc. proceeds from stock options exercised for fiscal 2024 was $3.33M, a 89.69% increase from fiscal 2023.
- Omada Health, Inc. proceeds from stock options exercised for fiscal 2023 was $1.75M.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $11.38M 10-Q · filed 2026-08-07 | $14.76M derived: sum of 3 quarters · filed 2026-08-07 | $16.84M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $3.25M 10-Q · filed 2026-05-08 | $6.62M derived: sum of 2 quarters · filed 2026-05-08 | $8.71M derived: sum of 3 quarters · filed 2026-05-08 | $11.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $5.46M derived: sum of 2 quarters · filed 2026-03-06 | $8.45M derived: sum of 3 quarters · filed 2026-08-07 | $9.37M 10-K · filed 2026-03-06 |
| 2025-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $5.07M derived: sum of 2 quarters · filed 2026-08-07 | $5.99M 10-Q · filed 2025-11-07 | $7.28M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $3.91M 10-Q · filed 2026-08-07 | $5.19M derived: sum of 3 quarters · filed 2026-08-07 | $5.86M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $919.00K 10-Q · filed 2026-05-08 | $2.20M derived: sum of 2 quarters · filed 2026-05-08 | $2.87M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $1.95M derived: sum of 2 quarters · filed 2026-03-06 | $3.33M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $666.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.04M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $1.38M 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $1.75M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |